首页> 美国卫生研究院文献>Indian Heart Journal >To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia

【2h】

To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia

机译：研究高剂量阿托伐他汀40 mg和80 mg在血脂异常患者中的作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Primary objective was to compare the effects of atorvastatin 40 mg vs 80 mg on LDL-C in Indian patients with atherosclerotic dyslipidemia. Secondary objectives were to compare the effects of atorvastatin 40 mg vs 80 mg on HDL-C and triglycerides and also comparing of side effects (myopathy, hepatotoxicity and new onset diabetes mellitus) of both doses.

机译：主要目的是比较印度动脉粥样硬化血脂异常患者中阿托伐他汀40 mg和80 mg对LDL-C的影响。次要目标是比较40毫克阿托伐他汀与80毫克阿托伐他汀对HDL-C和甘油三酸酯的作用，并比较两种剂量的副作用（肌病，肝毒性和新发糖尿病）。

著录项

期刊名称 Indian Heart Journal
作者
Deepak Agrawal; S.C. Manchanda; J.P.S. Sawhney; Bhuwanesh Kandpal; Rajneesh Jain; Ashwani Mehta; Arun Mohanty; Rajiv Passey; Aman Makhija; Manish Kr. Sharma;
展开▼
作者单位

展开▼
年(卷),期 2018(70),Suppl 3
年度 2018
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Atherosclerosis; Atorvastatin; Dyslipidemia; Myalgia;

机译：动脉硬化;阿托伐他汀;血脂异常;肌痛;
入库时间 2022-08-21 11:39:43

相似文献

外文文献
中文文献
专利

1. To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia [J] . Deepak Agrawal, S.C. Manchanda, J.P.S. Sawhney, Indian heart journal . 2018,第6期

机译：研究高剂量阿托伐他汀40 mg和80 mg在血脂异常患者中的作用
2. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 (PROVE IT-TIMI 22) Study). [J] . Tung P, Wiviott SD, Cannon CP, The American Journal of Cardiology . 2009,第8期

机译：固定剂量的普伐他汀（40 mg）或阿托伐他汀（80 mg）引起的急性冠状动脉综合征患者血脂的季节性变化（来自心肌梗死的普伐他汀或阿托伐他汀评估和感染治疗-血栓溶解（PROVE IT-TIMI 22）研究）。
3. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering (IDEAL) study). [J] . Tikkanen MJ, Holme I, Cater NB, The American Journal of Cardiology . 2009,第5期

机译：在65岁以下或≥65岁的冠心病患者中，阿托伐他汀（80毫克）与辛伐他汀（20至40毫克）的疗效和安全性比较（来自通过积极降脂（IDEAL）进行的增量减少）。
4. Using Therapeutic Circles to Visualize Guideline-Based Therapeutic Recommendations for Patients with Multiple Chronic Conditions: A Case Study with GO-DSS on Hypertension, Type 2 Diabetes, and Dyslipidemia [C] . Brigitte Seroussi, Alexra Galopin, Mouhssin Gaouar, MEDINFO . 2017

机译：使用治疗圆来可视化基于指南的治疗性建议，为多种慢性条件的患者进行：一种案例研究高血压的DSS，2型糖尿病和血脂血症
5. Antiplatelet activity to a high loading dose of clopidogrel quantified using point-of-care platelet aggregation assessment, is similar in diabetic versus non-diabetic patients [D] . Nathan, Sandeep 2008

机译：在糖尿病患者和非糖尿病患者中，通过即时护理血小板聚集评估定量的高剂量氯吡格雷抗血小板活性相似
6. Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial [O] . Monika Wagner, Peter Lindgren, Elizabeth Merikle, 2009

机译：在加拿大大剂量（80 mg /天）阿托伐他汀治疗与标准剂量（20 mg /天至40 mg /天）辛伐他汀治疗相比经济价值的评估是基于降低的激进性降脂终点（IDEAL））试用
7. PCV47 ROSUVASTATIN 40MG VERSUS ATORVASTATIN 80MG IN HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLAEMIA: ECONOMIC ANALYSIS OF THE POLARIS STUDY [O] . Miller PS, Leiter LA, Davies A, 2005

机译：高胆固醇血症的高危患者中PCV47罗伐他汀40毫克对阿托伐他汀80毫克：波兰人研究的经济分析

To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia

摘要

著录项

相似文献

相关主题

期刊订阅